1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow Relapse Multiple Myeloma: new trials by email Literature Review of Relapse Multiple Myeloma trials Research Report on Relapse Multiple Myeloma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Descartes-25 in Relapsed/Refractory Multiple Myeloma Descartes-25 - Multiple Myeloma, Relapse Multiple Myeloma | Phase 1 | Terminated | Cartesian Therapeutics | 9 | 2021-11-25 | 2024-11-12 |
Multiple Myeloma (1) · Neoplasms, Plasma Cell (1)
Blood Protein Disorders (1) · Cardiovascular Diseases (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Paraproteinemias (1) · Vascular Diseases (1)
Turkey (Türkiye) (1) · United States (1)